AmSurg receives 'buy' rating — 5 quick facts

Eleven analysts gave AmSurg shares a "buy" rating, according to The Vista Voice.

Here are five quick facts:

1. Analysts have a 12-month price target of $89.78 on AmSurg shares.

2. On April 13, AmSurg shares opened at $76.02.

3. The company's market cap is $4.07 billion.

4. AmSurg has a 50-day moving average of $72.12 and 200-day moving average of $75.26.

5. The company has a P/E ratio of 24.08.

More articles on surgery centers:
7 new joint venture ASCs — March/April 2016
Stamford ASC opens in Connecticut — 5 highlights
Mercy Health's plans for outpatient center advance — 5 points

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast